• Joseph G. Lossick
  • Stephen J. Kraus


Since its appearance in Europe over four centuries ago, syphilis has had a major impact on society. Its history is characterized by myth and superstition, and it has come to represent the prototype of venereal diseases that has been as associated with character weaknesses or debauchery as it has as a communicable disease.


Venereal Disease Serologic Screening Syphilis Infection Rapid Plasma Reagin Congenital Syphilis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Berry, C. D., Hooten, T. M., Collier, A. C., and Lukehart, S. A., Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with Hiv infection, N. Engl. J. Med. 316:1587–1589 (1987).PubMedCrossRefGoogle Scholar
  2. 2.
    Brown,W. J., Donohue, J. F., Axnick, N. W., Blount, J. H., Ewen, N. H., and Jones, O. G., Mortality caused by syphilis and its sequelae and other late manifestations of untreated venereal disease, in: Syphilis and Other Venereal Diseases, pp. 98–134, Harvard University Press, Cambridge, Mass., 1970.Google Scholar
  3. 3.
    Centers for Disease Control, Sexually Transmitted Disease Statistics 1985, Issue No. 135, U.S. Department of Health and Human Services.Google Scholar
  4. 4.
    Clarke, E. G., Studies in the epidemiology of syphilis. I. Material on which epidemiological studies are based; Ii. Contact investigation, Vener. Dis. Inf. 21:349–369 (1941).Google Scholar
  5. 5.
    Congenital syphilis-United States, 1983–1985, Morbid. Mortal. Weekly Rep. 35:625–628 (1986).Google Scholar
  6. 6.
    Drusin, L. M., Topf-Olstein, B., and Levy-Zombek, E., Epidemiology of infectious syphilis in a tertiary hospital, Arch. Intern. Med. 139:901–904 (1979).PubMedCrossRefGoogle Scholar
  7. 7.
    Dylewski, J., Chou, S., and Merigan, T. C., Absence of detectable IgM antibody during cytomegalovirus disease in patients with Aids [Letter], N. Engl. J. Med. 309:493 (1983).PubMedGoogle Scholar
  8. 8.
    Feldman, Y. M., Should premarital syphilis serologies continue to be mandated by law? Am. Med. Assoc. 240:459–460 (1978).CrossRefGoogle Scholar
  9. 9.
    Feldman, Y. M., Repeal of mandated premarital tests for syphilis: A survey of state health officers, Am. J. Public Health 71:155–159 (1981).CrossRefGoogle Scholar
  10. 10.
    Fichtner, R. R., Aral, S. O., Blount, J. H., Zaidi, A. A., Reynolds, G. H., and Darrow, W. W., Syphilis in the United States: 1967–1979, Sex. Transm. Dis. 10:77–80 (1983).PubMedCrossRefGoogle Scholar
  11. 11.
    Fieldsteel, A. H., and Miao, R. H., Genetics of treponema, in: Pathogenesis and Immunology of Treponemal Infection (R. F. Schell and D. M. Misher, eds.), Dekker, New York, 1982.Google Scholar
  12. 12.
    Fiumara, N., Fleming, W. L., Downing, J. G., and Good, F. L., The incidence of prenatal syphilis at the Boston City Hospital, N. Engl. J. Med. 247:48–52 (1952).PubMedCrossRefGoogle Scholar
  13. 13.
    Gjestland,T., The Oslo study of untreated syphilis: An epidemiologic investigation of the natural course of the syphilitic infection based on a re-study of the Boeck-Bruusgaard material, Acta Derm. Venereol. 35(Suppl. 34) (1955).Google Scholar
  14. 14.
    Hahn, R. A., Johnson, R. E., Magder, L. S., and Larsen, S. A., Follow-up study of syphilis infections detected in a 1978 U.S. survey, Presented at the 1987 Epidemic Intelligence Service Conference, p. 59, Cdc, Atlanta, April 1987.Google Scholar
  15. 15.
    Halpin, T. J., Costly and unnecessary syphilis serology, Ohio State Med. J. 7:536–537 (1980).Google Scholar
  16. 16.
    Hart, G., Screening to control infectious diseases: Evaluation of control programs for gonorrhea and syphilis, Rev. Infect. Dis. 2:701–712 (1980).PubMedCrossRefGoogle Scholar
  17. 17.
    Harter, C. A., and Benirschke, K., Fetal syphilis in the first trimester, Am. J. Obstet. Gynecol. 124:705–711 (1976).PubMedGoogle Scholar
  18. 18.
    Haskell, R. J., A cost-benefit analysis of California’s mandatory premarital screening program for syphilis, West. J. Med. 141:538–541 (1984).PubMedGoogle Scholar
  19. 19.
    Hicks, C. B., Bensen, P. M., Lupton, G. P., and Tramont, E. C., Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (Hiv) with Kaposi sarcoma, Ann. Intern. Med. 107:492–495 (1987).PubMedGoogle Scholar
  20. 20.
    Ho, P. W., Pien, F. D., and Pruett, K. A., Routine serological testing for syphilis in a community medical practice, West. J. Med. 132:485–487 (1980).PubMedGoogle Scholar
  21. 21.
    Huang, K. L., Ruben, F. L., Rinaldo, C. R., Kingsley, L., Lyter, D. W., and Ho, M., Antibody responses after influenza and pneumococcal immunization in Hiv-infected homosexual men, Am. Med. Assoc. 257:2047–2050 (1987).CrossRefGoogle Scholar
  22. 22.
    Huberich, C. H., Venereal disease in the law of marriage and divorce, Am. Law Rev. 37:226–236 (1903).Google Scholar
  23. 23.
    Jenkins, H., Cultivation of treponemes, in: Pathogenesis and Immunology of Treponemal Infections (R. F. Schell and D. M. Musher, eds.), Dekker, New York, 1982.Google Scholar
  24. 24.
    Johns, D. R., Tierney, M., and Felsenstein, D., Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus, N. Engl. J. Med. 316:1569–1572 (1987).PubMedCrossRefGoogle Scholar
  25. 25.
    Kampmeier, R. H., Syphilis, in: Bacterial Infections of Humans (A. S. Evans and H. A. Feldman, eds.), pp. 553–577, Plenum Medical, New York, 1982.CrossRefGoogle Scholar
  26. 26.
    Kingon, R. J., and Wiesner, P. J., Premarital syphilis screening: Weighing the benefits, Am. J. Public Health 71:160–162 (1981).PubMedCrossRefGoogle Scholar
  27. 27.
    Klingbeil, L. J., and Clark, E. G., Studies in the epidemiology of syphilis. III. Conjugal syphilis, Vener. Dis. Inf. 22:1–6 (1941).Google Scholar
  28. 28.
    Levene, G. M., Turk, J. L., Wright, D. M. J., and Grimble, A. G. S., Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis, Lancet 2:246–247 (1969).PubMedCrossRefGoogle Scholar
  29. 29.
    Luft, D. J., Conley, F., Remington, J. S., Laverdiere, M., Wagner, K. F., Levine, J. F., Craven, P. C., Strandberg, D. A., File, T. M., Rice, N., and Meuniercarpentier, F. Outbreak of central-nervous system toxoplasmosis in western Europe and North America, Lancet 1:781–784 (1983).PubMedCrossRefGoogle Scholar
  30. 30.
    Magnuson, H. J., Thomas, E. W., Orlansky, S., Kaplan, B. I., De Mello, L., Cutler,J. C., Inoculation syphilis in human volunteers, Medicine 35:33–82 (1956).PubMedCrossRefGoogle Scholar
  31. 31.
    Moore, M.D., Price, E.V., Knox, J.M., and Elgin,L.W., Epidemiological treatment of contacts to infectious syphilis, Public Health Rep. 78:966–970 (1963).PubMedCrossRefGoogle Scholar
  32. 32.
    Morrow, P. A., Report of the Committee of Seven of the Medical Society of the County of New York on the prophylaxis of venereal disease in New York City, N.Y. Med. J. 74:1146 (1901).Google Scholar
  33. 33.
    Morrow, P. A., The relations of social diseases to the family, Am. J. Soc. 14:635 (1909).CrossRefGoogle Scholar
  34. 34.
    National Center for Health Statistics, Findings on the serologic test for syphilis in adults: United States-1960–1962, Vital Health Stat. 11:1031 (1965).Google Scholar
  35. 35.
    Purrington, W. A., Professional secrecy and the obligatory notification of venereal diseases, N.Y. Med. J. 85:1207 (1907).Google Scholar
  36. 36.
    Pusey, W. A., The History and Epidemiology of Syphilis, pp. 53–61, Thomas, Springfield, Ill., 1933.Google Scholar
  37. 37.
    Roberts, C. J., Coccidioidomycosis in acquired immune deficiency syndrome. Depressed humoral as well as cellular immunity, Am. J. Med. 76:734–736 (1984).PubMedCrossRefGoogle Scholar
  38. 38.
    Rothenberg,R., Premarital syphilis serologies [Letter], J. Am. Med Assoc. 241:2007 (1979).CrossRefGoogle Scholar
  39. 39.
    Rothenberg, R., The geography of syphilis: A demonstration of epidemiologic diversity, in: Advances in Sexually Transmitted Diseases (Morisset, R. and Kurstak, E., eds.), pp. 125–133, Academic Press, New York, 1984.Google Scholar
  40. 40.
    Schroeter, A. L., Turner, R. H., Lucas, J. B., and Brown, W. J., Therapy for incubating syphilis: Effectiveness of gonorrhea treatment, J. Am. Med. Assoc. 218:711–713 (1971).CrossRefGoogle Scholar
  41. 41.
    Std Fact Sheet, Edition 35, Centers for Disease Control, Atlanta, 1979.Google Scholar
  42. 42.
    Stevenard, L., The professional secret in syphilis and marriage, Am. J. Urol. 12:33–37 (1916).Google Scholar
  43. 43.
    Strong, S. L., A symposium on the reportability and control of venereal diseases, Boston Med. Surg. J. 169:903–907 (1913).CrossRefGoogle Scholar
  44. 44.
    Syphilis-United States, 1983, Morbid. Mortal. Weekly Rep. 33(30):433–436 (1984).Google Scholar
  45. 45.
    Tomecki, K. J., and Tomecki, E. C., Neglect of syphilis in hospitalized patients, South. Med. J. 77:1118–1120 (1984).PubMedCrossRefGoogle Scholar
  46. 46.
    Vonderlehr, R. A., and Usilton, L. J., Syphilis among men of draft age in the United States, J. Am. Med. Assoc. 120:1369–1372 (1942).CrossRefGoogle Scholar
  47. 47.
    Ziegler, J. A., Jones, A. M., and Kubica, K. M., Demonstration of extracellular material at the surface of pathogenic T. pallidum cells, Br. J. Vener. Dis. 52:1–8 (1976).Google Scholar

12. Suggested Reading

  1. Brandt, A. M., No Magic Bullet: A Social History of Venereal Diseases in the United States Since 1880, Oxford University Press, London, 1985.Google Scholar
  2. Brown, W. J., Donohue, J. F., Axnick, N. W., Blount, J. H., Ewen, N. H., and Jones, O. G., Syphilis and Other Venereal Diseases, Harvard University Press, Cambridge, Mass., 1970.Google Scholar
  3. Centers for Disease Control, Morbid. Mortal. Weekly Rep. Std Treatment Guidelines 34(4S): 21–23 (1985).Google Scholar
  4. Centers for Disease Control, Guidelines for the Prevention and Control of Congenital Syphilis, Morbid. Mortal. Weekly Rep. 37(5–1):1–13 (1988).Google Scholar
  5. Centers for Disease Control, 1989 Sexually Transmitted Disease Treatment Guidelines. Morbid. Mortal. Weekly Rep. 38:1–43 (1989).Google Scholar
  6. Clark, E. G., and Danbolt, N., The Oslo study of the natural history of untreated syphilis, J. Chron. Dis. 2:311–344 (1955).PubMedCrossRefGoogle Scholar
  7. Gjestland, T., The Oslo study of untreated syphilis: An epidemiologic investigation of the natural course of the syphilitic infection based on a re-study of the Boeck—Bruusgaard material, Acta Derm. Venereol. 35(Suppl. 34) (1955).Google Scholar
  8. Holmes, K. K., Mardh, P. A., Sparling, P. F., Weisner, P. J., Catas, W., Lemon, S. M., and Stamm, W. E., Sexually Transmitted Diseases, McGraw—Hill, New York, 1990.Google Scholar
  9. Who Expert Committee on Venereal Diseases and Treponematoses, Sixth Report, World Health Organization Technical Report Series 736, World Health Organization, Geneva, 1986.Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Joseph G. Lossick
    • 1
  • Stephen J. Kraus
    • 1
  1. 1.Clinical Research Branch, Division of Sexually Transmitted Disease, Center for Prevention ServicesCenters for Disease ControlAtlantaUSA

Personalised recommendations